ConditionsEndometrial CancerEndometrial NeoplasmsObesity, MorbidGynecologic CancerGynecologic Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-75
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
About this trial
Data across literature suggest that robotic surgery may offer benefit specifically in patient with morbid obesity with endometrial cancer, but to date no randomized trials have been conducted to confirm these observations.
This randomized controlled multicentric trial aims to evaluate the most appropriate minimally invasive surgical approach in morbidly obese (BMI \>= 30) patients with endometrial carcinoma.
Eligibility criteria
Qualifiers
BMI >=30
Age > 18
Histologically confirmed endometrioid endometrial cancer
Clinical early stage (stage I)
Disqualifiers
High probability of laparotomy related to uterine volume (US estimated weight >250 g)
Concomitant pelvic disease, or anatomical characteristics of the patient
(Use of uterine manipulator)
Age >75 years
Trial design
Treatments tested in this trial
- Robot-assisted surgery
- Laparoscopic surgery
Treatment groups
566 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov